Created using Figma
Created using Figma
Revolutionizing the way medical innovations are supported.
Jun 30, 2018
Jul 30, 2018
100% completed
Raised funds - no Data
Company Details
Registered Country

About HeartChain

HeartChain Corporation is the very first global, decentralized, and blockchain-based sponsorship platform designed specifically for medical product development, currently typically undertaken by medical technology companies. The company mission is to provide medical technology innovators a straightforward and quick means of finding sponsorship than the existing, traditional go-to-market process. The key vision of the company is to provide medical technology developers an alternate, non-security-based route to the traditional venture capital source of funding, to ensure a much more efficient, rapid, and rewarding development cycle for high potential initiatives. HeartChain brings together a world-class management team with varied and robust medical and financial experience, along with their extensive networks of medical, scientific, and business experts. This combination brings a whole new level of knowledge and skill to the of worthwhile medical innovations identification process for our platform. Once the HeartChain management team selects the most deserving projects and products across multiple channels, the development of the selected projects will then be supported through a process of smart contracts and cryptocurrency tokenization. Leveraging blockchain technology creates numerous process efficiencies, such as the removal of hurdles experienced by traditional venture capital funding, as well as allows the medtech innovators the freedom to focus on what they do best: developing solutions that have the potential to revolutionize medicine and benefit the world.

HeartChain Roadmap

  • July 2018

  • Friends & Family Pre-TGE - end July
    Formation of Advisory Group - clinical & scientific experts
  • August 2018

  • Private Sale 1
    Finalisation of Advisory Group - clinical & scientific experts
  • September 2018

  • Private Sale 2
  • October 2018

  • Final development
  • Read More
  • November 2018

  • Beta Testing
  • December 2018

  • Platform Live - Public HCT Sale
    IPT#1 Launch


30 Days Growth:
30 Days Growth:

Participation in events

HeartChain Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Eytan Lombroso
Vice Chairman
Jean-Marc Orlando
Vice Chairman
Dr. Asher Holzer Phd
Simon Leger
COO & Head of Token Management


Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Jeremy Stone
Chairman of the Clinical Advisory Board

HeartChain Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.